Hayward, California-based drug startup Eikon Therapeutics closed a nearly $351 million Series D in the second-biggest round for a biotech startup this year.

Building a lasting business can take an exceedingly long time, but it's nothing compared to hundreds of well-known, ...

It is crucial that as a founder you do your homework and lay down proper foundations for scaling if you want your business to ...